Clinical trials
Terminated beta-Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 1 |
| Carelon Research | 1 |
| Celgene | 1 |
| Dana-Farber Cancer Institute | 1 |
| EdiGene (GuangZhou) Inc. | 1 |
| Fulcrum Therapeutics | 1 |
| Hamad Medical Corporation | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| La Jolla Pharmaceutical Company | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 14 |
| Anemia, Sickle Cell | 5 |
| Thalassemia | 4 |
| Hemoglobinopathies | 2 |
| Iron Overload | 2 |
| Anemia, Diamond-Blackfan | 1 |
| Cardiovascular Diseases | 1 |
| Heart Diseases | 1 |
| Hematologic Diseases | 1 |
| Hemoglobin SC Disease | 1 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.